Connect with us
https://tickernews.co/wp-content/uploads/2023/10/AmEx-Thought-Leaders.jpg

Tech

CSIRO launches program to foster medtech for SMEs

Published

on

Australia’s national science agency has announced an exciting opportunity for start-ups and small to medium-sized enterprises operating in the digital health and medical technology sectors.

The CSIRO invites applications for its upcoming “Innovate to Grow” program, aimed at driving innovation and advancement in these critical fields.

This 10-week online program, offered at no cost, has been specially designed to assist Australian SMEs in navigating the complex landscape of research and development (R&D) in digital health and medical technologies.

Helping SMEs Thrive

Professor Susie Nilsson, the Director of Biomedical Manufacturing Research at CSIRO, emphasised the program’s significance in fostering meaningful collaboration between research organizations and SMEs.

She noted that developing sustainable products in the digital health and medical technology sectors is a challenging and often underestimated process.

“The daunting task of navigating stringent testing and product development processes can be particularly overwhelming for SMEs,” Professor Nilsson said.

“Innovate to Grow presents a unique opportunity for businesses to gain valuable insights from industry experts about how research and development collaboration can help take their technology to the next level.

“In particular, the way in which businesses can advance from a research idea to a tangible R&D opportunity.”

READ MORE: The right startup funding choice

Unlocking Opportunities

Participants in the program will have the chance to collaborate with a mentor from CSIRO or a university.

This collaboration will address both technical and business challenges, helping SMEs explore R&D opportunities and gain insights into partnering with research organizations.

Additionally, participants will learn how to craft compelling R&D funding applications to support their projects.

Liz Crompton, SME Connect Program Advisor, highlighted the positive impact of the Innovate to Grow program since its inception.

“To date, Innovate to Grow has equipped over 500 businesses with the knowledge and tools to advance their ideas, with many program alumni initiating R&D projects with research organizations like CSIRO within 12 months of completing the program,” Ms. Crompton said.

R&D Funding

Participants may also become eligible for dollar-matched R&D funding through the CSIRO Kick-Start program, further enhancing their growth prospects.

The program is scheduled to commence on March 14, 2024, and is open to a limited number of SMEs operating in various sub-sectors within digital health and medical technology.

These sub-sectors include therapeutics and care, health system analytics, biomedical informatics and data modeling, as well as diagnostics, biosensors, biomedical devices, drug discovery, vaccines, and biologic therapeutics, among others.

Applications for CSIRO’s Innovate to Grow: Digital Health and Medical Technology program will be accepted until Sunday, February 18, 2024.

Find out more here.

Ahron Young is an award winning journalist who has covered major news events around the world. Ahron is the Managing Editor and Founder of TICKER NEWS.

Continue Reading

Shows

Is GenerativeAI transforming education?

Published

on

Educators today are facing an uphill battle, so what’s the solution?

Today’s educators are passionate, but they’re up against diverse classrooms and outdated teaching methods.

In this episode, Trevor Furness, Chief Revenue Officer of Octopus B-I discuss their efforts to transform education. #funding futures

Continue Reading

News

How AI is leveraging Amazon’s fast production

Published

on

Amazon reported better-than-expected results for the last quarter, surpassing analysts’ estimates.

Amazon reported better-than-expected results for the last quarter, surpassing analysts’ estimates, driven by strong performance in its cloud computing and AI.

Ticker’s Ahron Young & Veronica Dudo discuss.

Continue Reading

Tech

Tesla is slashing prices to stay competitive

Published

on

By

Tesla cut the U.S. prices of its Model Y, Model X and Model S vehicles by $2,000 each, days after the first-quarter deliveries of the world’s most valuable automaker missed market expectations.

Elon Musk’s electric-vehicle (EV) maker lowered the prices for its Model Y base variant to $42,990, while the long-range and performance variants are now priced at $47,990 and $51,490, respectively, according to its website.

The basic version of the Model S now costs $72,990 and its plaid variant $87,990. The Model X base variant now costs $77,990 and its plaid variant is priced at $92,900.
Tesla North America also said in a post on X said it would end its referral program benefits in all markets after April 30.

Referral program allows buyers to get extra incentives through referrals from existing customers, a strategy long used by traditional automakers to boost sales.

Musk has postponed a planned trip to India where he was to meet Prime Minister Narendra Modi and announce plans to enter the South Asian market, Reuters reported on Saturday.
On Monday Reuters reported, citing an internal memo, that the EV maker was laying off more than 10% of its global workforce.
Earlier this month Reuters reported the EV maker had canceled a long-promised inexpensive car, expected to cost $25,000, that investors had been counting on to drive mass-market growth.
The EV maker reported this month that its global vehicle deliveries in the first quarter fell for the first time in nearly four years, as price cuts failed to stir demand.

Tesla is to report first-quarter earnings on Tuesday.

Continue Reading
Live Watch Ticker News Live

Trending Now